• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4-disubstituted oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles 2,4-disubstituted oxazoles

Chemical Profile of (2-chloro-1,3-oxazol-4-yl)methanol (CAS No. 706789-06-2)

(2-chloro-1,3-oxazol-4-yl)methanol, with the CAS number 706789-06-2, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic alcohol features a unique structural framework that has garnered considerable attention from researchers due to its potential applications in drug development and medicinal chemistry. The presence of both a chloro substituent and a methanol group on the oxazole ring introduces distinct reactivity patterns, making it a versatile intermediate for constructing more complex molecular architectures.

The oxazole core, a five-membered aromatic ring containing two oxygen atoms, is well-documented for its role in various biologically active molecules. In particular, derivatives of oxazole have been explored for their antimicrobial, antiviral, and anti-inflammatory properties. The introduction of a chloro group at the 2-position enhances electrophilic substitution reactions, while the methanol moiety at the 4-position provides a nucleophilic site for further functionalization. This dual functionality makes (2-chloro-1,3-oxazol-4-yl)methanol an invaluable building block in synthetic protocols.

Recent advancements in medicinal chemistry have highlighted the importance of heterocyclic compounds in developing novel therapeutics. Studies have demonstrated that oxazole derivatives can modulate enzyme activity and interact with biological targets in unique ways. For instance, modifications to the oxazole ring have been shown to influence binding affinity and metabolic stability, key factors in drug design. The compound (2-chloro-1,3-oxazol-4-yl)methanol has been investigated as a precursor for synthesizing molecules that exhibit promising pharmacological effects.

In synthetic organic chemistry, the reactivity of (2-chloro-1,3-oxazol-4-yl)methanol allows for diverse transformations. The chloro group can undergo nucleophilic aromatic substitution or participate in cross-coupling reactions, enabling the introduction of additional functional groups. Concurrently, the methanol group can be oxidized to an aldehyde or esterified to form esters, expanding its utility in multi-step syntheses. These attributes have made it a preferred choice for chemists engaged in fragment-based drug discovery and library synthesis.

One notable application of this compound is in the development of kinase inhibitors. Kinases are enzymes involved in numerous cellular processes, and their dysregulation is associated with various diseases, including cancer. Researchers have leveraged the structural features of (2-chloro-1,3-oxazol-4-yl)methanol to design inhibitors that target specific kinase domains. The oxazole ring can mimic natural substrates or bind to allosteric sites on the kinase protein, while the chloro and methanol groups provide additional interactions to enhance binding affinity.

Furthermore, the compound has been explored in the context of developing antiviral agents. Viruses often rely on host cellular machinery for replication, making targeted inhibition an effective strategy. The structural motif of (2-chloro-1,3-oxazol-4-yl)methanol has been incorporated into molecules designed to disrupt viral protease activity or interfere with viral entry into host cells. Preliminary studies suggest that certain derivatives exhibit inhibitory effects against relevant viral strains.

The growing interest in green chemistry has also influenced the synthesis of (2-chloro-1,3-oxazol-4-yl)methanol. Efforts have been made to develop more sustainable synthetic routes that minimize waste and reduce hazardous byproducts. Catalytic methods and solvent-free reactions have been explored as alternatives to traditional approaches. These innovations align with global efforts to promote environmentally responsible chemical synthesis.

Computational chemistry has played a pivotal role in understanding the reactivity and potential applications of (2-chloro-1,3-oxazol-4-yl)methanol. Molecular modeling studies have provided insights into how different substituents influence electronic properties and interactions with biological targets. These predictions guide experimental design and accelerate the discovery process by identifying promising candidates for further investigation.

In conclusion, (2-chloro-1,3-oxazol-4-ylmethanol

• 706789-07-3(2-Chlorooxazole-4-carboxylic acid)
• 1240596-54-6((2-chloro-5-methyl-1,3-oxazol-4-yl)methanol)
• 1393584-83-2(2-(2-Chloro-1,3-oxazol-4-YL)propan-2-OL)
• 2344685-08-9(2-Chloro-4-methyloxazole hcl)
• 1060816-10-5(2-Chloro-4-methyloxazole)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)